Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludger Klein-Hitpass

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
International Journal of Colorectal Disease|December 23, 2004
Common denominator genes that distinguish colorectal carcinoma from normal mucosaRoland S Croner, Thomas Foertsch, Wolfgang M Brueckl, et al.
Epigenetics & Chromatin|July 28, 2017
Regions of common inter-individual DNA methylation differences in human monocytes: genetic basis and potential functionChristopher Schröder, Elsa Leitão, Stefan Wallner, et al.
Cancer Research|February 19, 2009
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapyJohannes H Schulte, Soyoung Lim, Alexander Schramm, et al.
Blood|December 7, 2014
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activityValentina Pettirossi, Alessia Santi, Elisa Imperi, et al.
International Journal of Cancer|October 19, 2007
MYCN regulates oncogenic MicroRNAs in neuroblastomaJohannes H Schulte, Sebastian Horn, Tobias Otto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 14, 2006
Nuclear export is essential for the tumor-promoting activity of survivinShirley K Knauer, Oliver H Krämer, Thomas Knösel, et al.
Acta Neuropathologica Communications|November 16, 2019
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Martin Mynarek, Inken Wohlers, et al.
Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.
Acta Neuropathologica|June 10, 2020
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Plos One|September 7, 2013
Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemiaMaria Göbel, Lewin Eisele, Michael Möllmann, et al.
International Journal of Colorectal Disease|December 23, 2004
Common denominator genes that distinguish colorectal carcinoma from normal mucosaRoland S Croner, Thomas Foertsch, Wolfgang M Brueckl, et al.
Epigenetics & Chromatin|July 28, 2017
Regions of common inter-individual DNA methylation differences in human monocytes: genetic basis and potential functionChristopher Schröder, Elsa Leitão, Stefan Wallner, et al.
Cancer Research|February 19, 2009
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapyJohannes H Schulte, Soyoung Lim, Alexander Schramm, et al.
Blood|December 7, 2014
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activityValentina Pettirossi, Alessia Santi, Elisa Imperi, et al.
International Journal of Cancer|October 19, 2007
MYCN regulates oncogenic MicroRNAs in neuroblastomaJohannes H Schulte, Sebastian Horn, Tobias Otto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 14, 2006
Nuclear export is essential for the tumor-promoting activity of survivinShirley K Knauer, Oliver H Krämer, Thomas Knösel, et al.
Acta Neuropathologica Communications|November 16, 2019
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Martin Mynarek, Inken Wohlers, et al.
Oncotarget|October 22, 2016
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsKathrin Fielitz, Kristina Althoff, Katleen De Preter, et al.
Acta Neuropathologica|June 10, 2020
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Felipe Andreiuolo, Martin Mynarek, et al.
Pageof 13